DGS Capital Management LLC decreased its position in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 17.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 20,033 shares of the company’s stock after selling 4,371 shares during the quarter. DGS Capital Management LLC’s holdings in SIGA Technologies were worth $120,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its holdings in SIGA Technologies by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 1,821,788 shares of the company’s stock worth $13,826,000 after purchasing an additional 133,883 shares during the last quarter. Renaissance Technologies LLC lifted its position in shares of SIGA Technologies by 404.1% during the 2nd quarter. Renaissance Technologies LLC now owns 92,936 shares of the company’s stock worth $705,000 after buying an additional 74,500 shares in the last quarter. AQR Capital Management LLC purchased a new position in shares of SIGA Technologies in the 2nd quarter worth approximately $99,000. SG Americas Securities LLC bought a new position in shares of SIGA Technologies in the third quarter valued at approximately $143,000. Finally, Creative Planning increased its position in shares of SIGA Technologies by 22.2% during the third quarter. Creative Planning now owns 39,137 shares of the company’s stock valued at $264,000 after acquiring an additional 7,114 shares during the last quarter. Hedge funds and other institutional investors own 55.40% of the company’s stock.
SIGA Technologies Trading Down 0.3 %
SIGA stock opened at $6.45 on Monday. The stock has a market cap of $460.56 million, a P/E ratio of 5.38 and a beta of 0.94. The stock’s fifty day simple moving average is $6.38 and its two-hundred day simple moving average is $7.51. SIGA Technologies, Inc. has a 1-year low of $4.26 and a 1-year high of $12.83.
SIGA Technologies Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Read More
- Five stocks we like better than SIGA Technologies
- What does consumer price index measure?
- MP Materials: Rare Earth Elements Powering the EV Boom
- Manufacturing Stocks Investing
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.